Thermo Fisher Scientific Trading Volume Drops 30.89% to 11.53 Billion Shares Ranked 1st in Decline

On April 11, 2025, Thermo Fisher Scientific (TMO) experienced a significant decline in trading volume, with a total of 11.53 billion shares traded, marking a 30.89% decrease from the previous day. Despite this, the stock price rose by 2.51%.

Analysts have maintained a bullish outlook on Thermo Fisher Scientific. Eve Burstein from Bernstein reiterated a Buy rating on the company, setting a price target of $690.00. This sentiment is echoed by RBC Capital, which also maintained a Buy rating with a price target of $694.00. The consensus among analysts is a Strong Buy, with an average price target of $649.75, suggesting a 45.6% upside from current levels.

Thermo Fisher Scientific's strong position in the healthcare sector is further supported by its diverse product offerings and robust financial performance. The company's focus on innovation and strategic acquisitions has positioned it well to capitalize on growth opportunities in the medical and scientific research markets.